摘要
本研究对奥贝胆酸(1)的合成工艺进行了优化。3α-羟基-7-氧代-5β-胆烷酸(2)经酯化和3-位硅烷化得3α-三甲基硅氧基-7-氧代-5β-胆烷酸甲酯(4)。以三氟甲磺酸三甲基硅基酯代替传统的烯醇化试剂三甲基氯硅烷,在-10℃即可将4完全转化为3α,7-二(三甲基硅氧基)-6-烯-5β-胆烷酸甲酯(5),收率由64.3%提高至98.0%。使用三氟化硼乙腈代替三氟化硼乙醚作羟醛缩合剂,使5与乙醛反应得3α-羟基-6-亚乙基-7-氧代-5β-胆烷酸甲酯(6),收率由70.0%提高至93.2%。6经加氢还原、水解和7-位羰基还原得1。优化后的工艺操作简便,反应条件温和,成本低,总收率由24.6%提高至73.6%(以2计)。
The synthetic process of obeticholic acid(1) was improved. Methyl 3α-[(trimethylsilyl)oxy]-7-oxo-5β-cholanate(4) was synthesized via esterification and silicon alkylation from 3α-hydroxy-7-oxo-5β-cholanic acid(2).Compound 4 was completely converted to methyl 3α,7-di[(trimethylsilyl)oxy]-5β-cholanate(5) at -10 ℃ , and the yield was increased from 64.3% to 98.0% by using trimethylsilyl triflate as the enolization reagent. Then 5 reacted with acetaldehyde in the presence of boron trifluoride acetonitrile complex to give methyl 3α-hydroxy-6-ethylidene-7-oxo-5β-cholanate (6) in a yield of 93.2% , which was 23.2% higher than the literature. Then 6 was subjected to hydrogenation,hydrolysis and carbonyl reduction to provide 1. The improved synthetic route simplified the reaction conditions and operation procedure, and also gave a better overall yield of 73.6% (based on 2)with a purity of 99.0% .
出处
《中国医药工业杂志》
CAS
CSCD
北大核心
2017年第7期1002-1005,共4页
Chinese Journal of Pharmaceuticals
关键词
奥贝胆酸
胆烷酸
法尼醇X受体
肝硬化
硅烷化
烯醇化
合成工艺
obeticholic acid
bile acid
farnesoid X receptor
cirrhosis
silicon alkylation
enolization
synthetic process